Endpoints News recently interviewed our CEO, Jason Gardner, to discuss Ampersand Biomedicines’ exciting new collaboration with Pfizer under its Flagship Pioneering partnership. Through our AND™ Platform, we’re working to develop programmable biologics —targeting disease sites directly to maximize activity while sparing healthy tissues. By doing this, we can create potent therapies without compromising on safety or tolerability to unlock the full potential of therapies. Read the full article to learn more about our collaboration and how we’re advancing innovation in obesity and beyond: https://bit.ly/498Yl3g #FlagshipFounded
About us
Ampersand Biomedicines enables a new way of designing programmable medicines that work precisely where needed in the body and nowhere else. The company’s state-of-the-art computationally powered Address, Navigate, Design (AND)™ Platform continually learns the rules for identifying optimal localizer targets and refines its ability to design across the complex space of localizers and actuators. The result is increasingly sophisticated AND-Body™ therapeutics that are engineered across the physical constraints of molecules and the biological characteristics of the targets to effectively target the site of disease without affecting healthy tissue or cells. Ampersand Biomedicines was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering.
- Website
-
https://www.ampersand.bio/
External link for Ampersand Biomedicines
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2021
Employees at Ampersand Biomedicines
Updates
-
Today, we announced a new collaboration under the Flagship Pioneering-Pfizer partnership to leverage our AND™ Platform to identify programmable biologics for the treatment of obesity. Our AND-Body™ Therapeutics are designed to target disease sites precisely, to drive better activity without affecting healthy tissues or cells. This collaboration is just one of many potential applications of our platform in obesity and beyond. Read more about our first partnership and learn how we’re unlocking novel approaches to targets in disease areas of significant unmet need: https://bit.ly/3YWeGni #Biotech #Innovation #DrugDevelopment #FlagshipFounded
-
-
Imagine sending medicines precisely to where they are needed in the body and nowhere else. We're making this vision a reality through our AND™️ Platform, which powers the production of programmed biologics, called AND-Body therapeutics. Watch the full video and learn about our approach: https://bit.ly/3Md1YKX #biotechnology #drugdevelopment
-
#ANDinnovator spotlight! Claudia Wurzenberger, VP of Project Management, says she was late to discover her love for STEM, and would have never envisioned a career in science until some inspiring teachers and supportive parents encouraged her to follow her own path. That journey led her to Ampersand, where she's able to pursue her passion alongside a diverse, collaborative team. Learn more about our work and explore open positions: https://bit.ly/47kgUAP #biotechnology #innovation #drugdevelopment
-
Welcome to the newest #ANDInnovators! This past quarter, we had the pleasure of welcoming Kyriakos Economides, Justin Winkel, Petya Koleva, Lucie Krejbichová, and Eliška Frantová to our pioneering team as we drive to make a difference for patients. We're also thrilled to have Nhan Nguyen, Shahad T., and Yao Tang join us as co-ops for the rest of the year. Please join us in welcoming our new teammates! Visit our careers page to see open positions and learn about our vibrant culture: https://lnkd.in/gfcsQJY7 #biotechnology #biotechcareers
-
-
AND-Body™ Therapeutics are programmable medicines that work precisely where needed in the body and nowhere else. By using our computationally powered AND™️ Platform, we can treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. Learn more about our science: https://bit.ly/3Md1YKX #biotechnology #innovation
-
Companies pioneering original science, such as our AND-Platform, are essential to bring about new medicines for patients. We are proud to be part of the #FlagshipFounded ecosystem of companies doing bold science to make #biggerleaps for patients.
Flagship Pioneering raises $3.6 billion to fuel critical breakthroughs in human health and sustainability. This expanded capital pool will accelerate the impact of original science and the creation and development of an estimated 25 breakthrough companies in human health, sustainability, and artificial intelligence. Hear from Flagship Founder and CEO Noubar Afeyan about how we're taking #BiggerLeaps by leveraging the power of generative AI, forging novel partnerships with pharma to speed drug development, expanding globally, and promoting and hiring top talent to our leadership ranks. Read the full press release: https://bit.ly/4eQfx05
-
Last week, we attended the Flagship Pioneering AI Engineering Hackathon, an event hosted with Amazon Web Services (AWS) focused on building AI tools to enable asking natural language questions over our datasets. Members from Ampersand's computational biology team developed a system using state-of-the-art large language models and AWS resources to efficiently query our proprietary AND-Platform™️ address map. The system was presented during the hackathon, earning them the 'Most Practical Solution' award. Congrats, Team Ampersand! #innovation #biotechnology #AI #ML #ANDinnovators
-
-
Did you know that we acquired the antibody discovery company, AbCheck s.r.o.? Hear from our CEO, Jason Gardner to learn how this acquisition amplifies our in-house capabilities to generate programmed biologics across a broad range of diseases. #drugdevelopment #innovation #biotechnology
-
As we end an incredibly busy first quarter, please join us in extending a warm welcome to the newest #ANDInnovators! We're thrilled to welcome Natalie Lissy, Joe Brady, Ranjit Randhawa, May Lee, Pratibha Singh, Yue (Shawn) Shen, and Bo Li to our growing team, and look forward to 2024 and beyond. At Ampersand, we're proud to support the next generation of #STEM professionals and are excited to have Yesha Italiya, Tarun Saxena, and Sahil Bodke join us as co-ops for the first half of the year. Check out our careers page to learn about life at Ampersand and see our open positions: https://lnkd.in/gfcsQJY7 #nowhiring #biotechnology #innovation #careers
-